Kieron Dunleavy, MD is a Professor of Medicine, Director of the Lymphoma Program and Co-Director of the Microbial Oncology Program in the Division of Hematology & Oncology and the GWU Cancer Center.
Dr. Dunleavy is a medical oncologist who completed fellowships in Dublin, Ireland and subsequently at the National Cancer Institute (NCI), Bethesda. Following his fellowship at the NCI, he remained on staff as an attending physician and over the past few years, has been the Clinical Director of the Lymphoid Malignancies Branch at the NCI. Dr. Dunleavy is an expert in lymphoid malignancies and his work has focused on the biology and treatment of lymphoid diseases. His interests include aggressive and indolent lymphomas and viral/microbial associated lymphoid diseases such as those associated with EBV and HIV. He serves on the scientific advisory board of the Lymphoma Research Foundation and on the editorial board of several journals including Blood, Haematologica and Leukemia and Lymphoma. Dr. Dunleavy has published over 100 manuscripts and textbook chapters and frequently presents his work nationally and internationally.